Bibliography May 2006

  1. ALEXIS AFet STROBER BE: Off-Label Dermatologic Uses of Anti-TNF-a Therapies, J Cutan Med Surg., Vol. ., 2006
    Organism:Department of Dermatology, St Luke's-Roosevelt Hospital Center, New York, NY, USA
    Abstract:    BACKGROUND: Tumor necrosis factor-alpha (TNF-a) is a proinflammatory cytokine that plays an immunomodulatory role in a variety of systemic and dermatologic diseases. Currently, three anti-TNF-a drugs are available in North America- infliximab (approved in the U.S. for the treatment of rheumatoid arthritis, Crohn's disease, ankylosing spondylitis, ulcerative colitis, and psoriatic arthritis), etanercept (approved in the U.S. for the treatment of rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and psoriasis), and adalimumab (approved for the treatment of rheumatoid arthritis and psoriatic arthritis). OBJECTIVE: To review the current literature supporting alternative (and currently off-label) dermatologic uses of TNF-a antagonists. METHODS: A MEDLINE search (1966-March 2005) was conducted using the keywords "infliximab," "etanercept," "adalimumab," "TNF inhibitors," and "off-label" to identify published reports of off-label dermatologic uses of TNF-a inhibitors. RESULTS: Anti-TNF-a therapies have been reported in the following dermatologic diseases: sarcoidosis, hidradenitis suppuritiva, cicatricial pemphigoid, Behcet's disease, pyoderma gangrenosum, multicentric reticulohistiocytosis, apthous stomatitis, Sneddon-Wilkinson disease, SAPHO syndrome, pityriasis rubra pilaris, eosinophilic fasciitis, panniculitis, Crohn's disease, necrobiosis lipoidica diabeticorum, dermatomyositis, and scleroderma. The vast majority of these reports are in the form of individual case reports and small case series. Only two published randomized controlled trials involving the off-label use of a TNF inhibitor were found. CONCLUSIONS: A growing number of published reports suggest that anti-TNF-a therapies may be effective in the treatment of numerous inflammatory skin diseases outside their currently approved indications

  2. ANZILOTTI C, MERLINI G, PRATESI F, TOMMASI C, CHIMENTI Det MIGLIORINI P: Antibodies to viral citrullinated peptide in rheumatoid arthritis, J Rheumatol., Vol. 33, 647-651., 2006
    Organism:Clinical Immunology Unit, Department of Internal Medicine, University of Pisa, Pisa, ItalyFAU - Anzilotti, Consuelo
    Abstract:    OBJECTIVE: To analyze the frequency of anti-viral citrullinated peptide (anti-VCP) antibodies in sera from patients with rheumatoid arthritis (RA) by an Epstein-Barr virus (EBV)-derived peptide in which arginine is replaced with citrulline.METHODS: Anti-VCP antibodies were determined in 627 serum samples, 300 from patients with RA and 327 from controls, including connective tissue diseases, chronic arthritides, and healthy donors. Among patients with RA, a possible correlation with systemic involvement, disease severity, and disease activity was investigated; in 94 RA patients antibodies to cyclic citrullinated protein (anti-CCP) were also measured. RESULTS: Anti-VCP antibodies were found in 45% of RA sera versus less than 5% of controls; anti-VCP levels correlated with anti-CCP levels (p < 0.0001), rheumatoid factor (p = 0.02), and erythrocyte sedimentation rate (p = 0.0058). No correlation was found with extraarticular manifestations of the disease or with disease severity. CONCLUSION: Anti-VCP antibodies are helpful in discriminating RA from other chronic arthritides or connective tissue disorders. The level of positivity is positively correlated with the anti-CCP level, suggesting that VCP can be considered a novel substrate to detect anti-citrullinated peptide/protein antibodies (ACPA). The reactivity of RA-specific antibodies with a viral citrullinated antigen raises questions on the role of EBV in the induction of ACPA

  3. APRIL KT, FELDMAN DE, PLATT RWet DUFFY CM: Comparison between Children with Juvenile Idiopathic Arthritis (JIA) and their Parents Concerning Perceived Quality of Life, Qual Life Res., Vol. 15, 655-661., 2006
    Organism:Ecole de Readaptation, Universite de Montreal, CP 6128, Succ Centre-ville, Montreal, Quebec, H3C 3J7, Canada , ktoupinapril@umontrealcaFAU - April, Karine Toupin
    Abstract:    The aim of the study was to determine the level of agreement between the perceptions of children with JIA and their parents concerning quality of life. Fifty patients aged 9-18 years and their parents, who attended the JIA clinic at the Montreal Children's Hospital, completed the Juvenile Arthritis Quality of Life Questionnaire (JAQQ). Paired t-tests were employed to compare parents' and children's scores and agreements were analyzed by intraclass correlation coefficients (ICCs). Linear regression was used to explore factors associated with agreements and with the perceptions of quality of life. ICCs (95% confidence interval) for the subscales of the JAQQ were 0.62 (0.42,0.77) for gross motor function, 0.35 (0.08,0.57) for fine motor function, 0.61 (0.41,0.76) for psychosocial function, 0.70 (0.52,0.82) for systemic symptoms and 0.60 (0.38,0.75) for pain. Agreement was higher for psychosocial function among younger children and for overall quality of life among those who had the disease longer. Higher agreement levels on pain were associated with more severe disease. Disease severity was associated with perceptions of quality of life (p < 0.01). There seems to be good agreement between the perceptions of children with JIA and their parents concerning quality of life, except for fine motor function

  4. BOTTINI N, VANG T, CUCCA Fet MUSTELIN T: Role of PTPN22 in type 1 diabetes and other autoimmune diseases, Semin Immunol., Vol. ., 2006
    Organism:Institute for Genetic Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, United States
    Abstract:    We recently discovered that a single-nucleotide polymorphism (SNP) in the lymphoid tyrosine phosphatase (LYP), encoded by the PTPN22 gene on chromosome 1p13, correlates strongly with the incidence of type 1 diabetes (T1D) in two independent populations. This findings has now been verified by numerous studies and it has been expanded to rheumatoid arthritis, juvenile rheumatoid arthritis, systemic lupus erythematosus, Graves' disease, generalized vitiligo and other autoimmune disease. Here we review the genetics of the SNP and its association with autoimmunity, discuss the function of the phosphatase in signaling, the biochemistry of the disease-predisposing allele, and the possible mechanisms by which PTPN22 contributes to the development of human disease

  5. BRINAR VV, PETELIN Z, BRINAR M, DJAKOVIC V, ZADRO Iet VRANJES D: CNS demyelination in autoimmune diseases, Clin Neurol Neurosurg., Vol. 108, 318-326., 2006
    Organism:University Department of Neurology, Zagreb School of Medicine and University Hospital Center, Kispaticeva 12, Zagreb, Croatia vesnabrinar@zghtnethrFAU - Brinar, Vesna V
    Abstract:    Autoimmune diseases represent a diverse group of disorders that have generally of unknown etiology and poorly understood pathogenesis. They may be organ-specific or systemic, giving rise to overlapping syndromes; more than one autoimmune disease may occur in the same patient. Numerous case reports have documented that multiple sclerosis (MS) may be present concurrently with other autoimmune diseases, most commonly rheumatoid arthritis, autoimmune thyroid disease, type I diabetes mellitus and pernicious anemia. Case reports of disseminated encephalomyelitis (DEM) coincidental with other autoimmune diseases are rare. Many of systemic autoimmune diseases cause central nervous system (CNS) demyelination and are frequently then diagnosed as MS, whereas they often are instances of DEM, the result of vascular, granulomatous or postinfectious manifestations. We have reviewed 15 patients with autoimmune diseases and CNS demyelination in order to determine the nature of the demyelinating process

  6. BUESO MB, CABALLERO R, CASTRO HJ, BARAKAT Aet BELLANTI JA: Recurrent infections and joint pain, Allergy Asthma Proc., Vol. 27, 164-171., 2006
    Organism:International Center for Interdisciplinary Studies of Immunology, Georgetown University Medical Center, Washington, DC 20057, USAFAU - Bueso, Monica B
    Abstract:    A seven-year-old white male presented with recurrent bouts of paranasal sinusitis, streptococcal pharyngotonsillitis, lower respiratory tract infections, continuous low-grade fever, and conjunctivitis, which required frequent use of antibiotics over a period of two years. A careful review of systems also revealed a six-month history of arthralgia affecting his knees, elbows, and hands, which limited his daily activities. Prominent in the history were recurrent bouts of a generalized salmon-red, nonpruritic rash, which was most pronounced on the face and trunk and which was exacerbated by fever. His past medical history revealed severe bouts of gastroesophageal reflux disease, chronic intermittent bloody mucous diarrhea, and atopic dermatitis. A detailed review of the patient's family pedigree over five generations revealed a strong genetic predisposition for autoimmune diseases of several types. His physical examination revealed a thin, pale, chronically ill-appearing male, bilateral conjunctivitis, and pale nasal mucosae with no lymphadenopathy, organomegaly, arthritis, or rash. All laboratory results were unremarkable except for a positive rheumatoid factor and a suboptimal antibody response to immunization with pneumococcal vaccine. A diagnosis of juvenile rheumatoid arthritis of the systemic onset type was established, and, based upon his humoral immune deficiency, treatment with intravenous immunoglobulin was initiated with remarkable improvement in his symptomatology

  7. CASSIDY J, KIVLIN J, LINDSLEY Cet NOCTON J: Ophthalmologic examinations in children with juvenile rheumatoid arthritis, Pediatrics., Vol. 117, 1843-1845., 2006
    Organism:

  8. DOMINICK KL, GOLIGHTLY YMet JACKSON GL: Arthritis prevalence and symptoms among US non-veterans, veterans, and veterans receiving Department of Veterans Affairs Healthcare, J Rheumatol., Vol. 33, 348-354., 2006
    Organism:Center for Health Services Research in Primary Care of the Durham VAMC, NC 27705, USA domin004@mcdukeeduFAU - Dominick, Kelli L
    Abstract:

  9. EMERY P, KOSINSKI M, LI T, MARTIN M, WILLIAMS GR, BECKER JC, BLAISDELL B, WARE JE, Jr., BIRBARA Cet RUSSELL AS: Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life, J Rheumatol., Vol. 33, 681-689., 2006
    Organism:Rheumatology and Rehabilitation Research Unit, University of Leeds, UK pemery@leedsacukFAU - Emery, Paul
    Abstract:

  10. EVENSEN KJet NOSSENT HC: Epidemiology and outcome of adult-onset Still's disease in Northern Norway, Scand J Rheumatol., Vol. 35, 48-51., 2006
    Organism:Department of Rheumatology, Institute of Clinical Medicine, University of Tromso, NorwayFAU - Evensen, K J
    Abstract:

  11. GARG AX, MARSHALL J, SALVADORI M, THIESSEN-PHILBROOK HR, MACNAB J, SURI RS, HAYNES RB, POPE Jet CLARK W: A gradient of acute gastroenteritis was characterized, to assess risk of long-term health sequelae after drinking bacterial-contaminated water, J Clin Epidemiol., Vol. 59, 421-428., 2006
    Organism:Department of Medicine, University of Western Ontario, London, Ontario, Canada AmitGarg@lhsconcaFAU - Garg, Amit X
    Abstract:

  12. HALLERT E, HUSBERG Met SKOGH T: Costs and course of disease and function in early rheumatoid arthritis: a 3-year follow-up (the Swedish TIRA project), Rheumatology (Oxford)., Vol. 45, 325-331., 2006
    Organism:Division of Rheumatology/AIR, Department of Molecular and Clinical Medicine, Faculty of Health Sciences, Linkoping University Hospital, Linkoping, SwedenFAU - Hallert, E
    Abstract:

  13. HEAD AJ, MYERS LK, WATSKY MA, GREENWELL MW, BARROW KD, MICHELSON JAet CARBONE LD: Bone mineral density and turnover in non-corticosteroid treated African American children with juvenile rheumatoid arthritis, J Rheumatol., Vol. 33, 1001-1003., 2006
    Organism:Department of Medicine, Division of Rheumatology; Children's Foundation Research Center at LeBonheur Children's Medical Center; University of Tennessee Health Sciences Center, Memphis, Tennessee 38163, USAFAU - Head, Andrew J
    Abstract:

  14. HEINZ C, KOCH JMet HEILIGENHAUS A: Transscleral diode laser cyclophotocoagulation as primary surgical treatment for secondary glaucoma in juvenile idiopathic arthritis: high failure rate after short term follow up, Br J Ophthalmol., Vol. 90, 737-740., 2006
    Organism:MD, Department of Ophthalmology, St Franziskus-Hospital, Muenster, Hohenzollernring 54, 48145 Muenster, Germany carstenheinz@uveitis-zentrumdeFAU - Heinz, C
    Abstract:

  15. HURWITZ ELet CHIANG LM: A comparative analysis of chiropractic and general practitioner patients in North America: findings from the joint Canada/United States Survey of Health, 2002-03, BMC Health Serv Res., Vol. 6:49., 49, 2006
    Organism:Department of Public Health Sciences and Epidemiology, John A Burns School of Medicine, University of Hawaii-Manoa, Biomed, D-104H, Honolulu, Hawaii 96822, USA ehurwitz@hawaiieduFAU - Hurwitz, Eric L
    Abstract:

  16. JONES OY, SPENCER CH, BOWYER SL, DENT PB, GOTTLIEB BSet RABINOVICH CE: A multicenter case-control study on predictive factors distinguishing childhood leukemia from juvenile rheumatoid arthritis, Pediatrics., Vol. 117, e840-e844, 2006
    Organism:Department of Pediatric Rheumatology, Children's National Medical Center, George Washington University, Washington, DC 20010, USA oyjones@cnmcorgFAU - Jones, Olcay Y
    Abstract:

  17. JORDAN Aet MCDONAGH JE: Juvenile idiopathic arthritis: the paediatric perspective, Pediatr Radiol., Vol. ., 2006
    Organism:Department of Adolescent Rheumatology, Birmingham Children's Hospital, Birmingham, UK
    Abstract:

  18. KALICHMAN L, LIVSHITS Get KOBYLIANSKY E: Indices of body composition and chronic morbidity: a cross-sectional study of a rural population in central Russia, Am J Hum Biol., Vol. 18, 350-358., 2006
    Organism:Department of Physical Therapy, Stanley Steyer School of Health Professions, Tel Aviv University, Tel Aviv 69978, IsraelFAU - Kalichman, Leonid
    Abstract:

  19. KANG M, WANG HW, CHENG PX, YIN ZD, LI XO, SHI Het HU XF: Lack of association between mannose-binding lectin gene polymorphisms and juvenile idiopathic arthritis in a Han population from the Hubei province of China, Arthritis Res Ther., Vol. 8, R85, 2006
    Organism:Department of Pediatrics, Tongji Hospital, Tongji Medical College, Hua Zhong University of Science and Technology, 1095 Jie Fang Avenue, Wuhan 430030, Hubei Province, China hwwang@tjhtjmueducn
    Abstract:

  20. KELLER-MARCHAND L, FARPOUR-LAMBERT NJ, HANS D, RIZZOLI Ret HOFER MF: Effects of a Weight-bearing Exercise Program in Children with Juvenile Idiopathic Arthritis: 979: 2:30 PM - 2:45 PM, Med Sci Sports Exerc., Vol. 38, S93-S94, 2006
    Organism:1Sports Medicine, Deptof Pediatrics, University Hospital, Geneva 14, Switzerland 2Div of Nuclear Medicine, University Hospital, Geneva 14, Switzerland 3Service of Bone Diseases, University Hospital, Geneva 14, Switzerland 4Multisite Center of Pediatric Rheumatology, University Hospitals, Geneva and Lausanne, Switzerland
    Abstract:

  21. KILLEEN OGet GARDNER-MEDWIN JM: In juvenile idiopathic arthritis, is folate supplementation effective against methotrexate toxicity at the expense of methotrexate's efficacy?, Arch Dis Child., Vol. 91, 537-538., 2006
    Organism:Paediatric Rheumatology, Department of Child Health, RHSC, Glasgow, UK orlakilleen@doctorsorgukFAU - Killeen, O G
    Abstract:

  22. KOZYRO I, PERAHUD I, SADALLAH S, SUKALO A, TITOV L, SCHIFFERLI Jet TRENDELENBURG M: Clinical value of autoantibodies against C1q in children with glomerulonephritis, Pediatrics., Vol. 117, 1663-1668., 2006
    Organism:Department of Pediatrics, 2nd Children's Hospital, Belarus State University, Minsk, BelarusFAU - Kozyro, Ina
    Abstract:

  23. LESHEM D, TOMPSON B, BRITTO JA, FORREST CRet PHILLIPS JH: Orthognathic surgery in juvenile rheumatoid arthritis patients, Plast Reconstr Surg., Vol. 117, 1941-1946., 2006
    Organism:Center for Craniofacial Care and Research, Division of Plastic Surgery, Department of Orthopedics, The Hospital for Sick Children, Toronto, Ontario, CanadaFAU - Leshem, David
    Abstract:

  24. LOVELL DJ, REIFF A, JONES OY, SCHNEIDER R, NOCTON J, STEIN LD, GEDALIA A, ILOWITE NT, WALLACE CA, WHITMORE JB, WHITE Bet GIANNINI EH: Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis, Arthritis Rheum., Vol. 54, 1987-1994., 2006
    Organism:Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
    Abstract:

  25. MELO FM, CAVALCANTI MS, SANTOS SB, LOPES AKet OLIVEIRA FA: [Association between serum markers for celiac and thyroid autoimmune diseases], Arq Bras Endocrinol Metabol., 1919
    Organism:Departamento de Patologia, Faculdade de Ciencias Medicas, Universidade de Pernambuco, Recife, PEFAU - Melo, Francisco M de
    Abstract:

  26. NALEPKA JL, LEE MJ, KRAAY MJ, MARCUS RE, GOLDBERG VM, CHEN Xet GREENFIELD EM: Lipopolysaccharide Found in Aseptic Loosening of Patients with Inflammatory Arthritis, Clin Orthop Relat Res., Vol. ., 2006
    Organism:From the Departments of *Orthopaedics, daggerPhysiology and Biophysics, and double daggerPathology, Case Western Reserve University, University Hospitals of Cleveland, Cleveland, OH
    Abstract:

  27. NORDMARK B, BLOMQVIST P, ANDERSSON B, HAGERSTROM M, NORDH-GRATE K, RONNQVIST R, SVENSSON Het KLARESKOG L: A two-year follow-up of work capacity in early rheumatoid arthritis: a study of multidisciplinary team care with emphasis on vocational support, Scand J Rheumatol., Vol. 35, 7-14., 2006
    Organism:Rheumatology Unit, Department of Medicine at Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden birgittanordmark@karolinskaseFAU - Nordmark, B
    Abstract:

  28. OSWALD AE, PYE SR, O'NEILL TW, BUNN D, GAFFNEY K, MARSHALL T, SILMAN AJet SYMMONS DP: Prevalence and associated factors for falls in women with established inflammatory polyarthritis, J Rheumatol., Vol. 33, 690-694., 2006
    Organism:ARC Epidemiology Unit, The University of Manchester, UKFAU - Oswald, Anna E
    Abstract:

  29. PEAKE NJ, KHAWAJA K, MYERS A, NOWELL MA, JONES SA, ROWAN AD, CAWSTON TEet FOSTER HE: Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor, Rheumatology (Oxford)., Vol. ., 2006
    Organism:Musculoskeletal Research Group, School of Clinical Medical Sciences, University of Newcastle-upon-Tyne, UK
    Abstract:

  30. PIPINOS II, HOPP R, EDWARDS WDet RADIO SJ: Giant-cell temporal arteritis in a 17-year-old male, J Vasc Surg., Vol. 43, 1053-1055., 2006
    Organism:Department of Surgery, University of Nebraska Medical Center, Omaha, USAFAU - Pipinos, Iraklis I
    Abstract:

  31. REN H, CHEN N, CHEN X, FU X, JIANG Y, HAO Cet DONG D: [Clinical and pathologic analysis of Sjogren's syndrome with renal impairment: a report of 84 cases], Zhonghua Nei Ke Za Zhi., Vol. 40, 367-369., 2001
    Organism:Department of Nephrology, Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025, ChinaFAU - Ren, H
    Abstract:

  32. RUPP I, BOSHUIZEN HC, ROORDA LD, DINANT HJ, JACOBI CEet VAN DEN BG: Course of patient-reported health outcomes in rheumatoid arthritis: comparison of longitudinal and cross-sectional approaches, J Rheumatol., Vol. 33, 228-233., 2006
    Organism:Department of Social Medicine, Academic Medical Center, University of Amsterdam, The Netherlands irupp@amcuvanlFAU - Rupp, Ines
    Abstract:

  33. SIJSSENS KM, ROTHOVA A, BERENDSCHOT TTet DE BOER JH: Ocular hypertension and secondary glaucoma in children with uveitis, Ophthalmology., Vol. 113, 859-2., 2006
    Organism:FC Donders Institute of Ophthalmology, University Medical Center, Utrecht, The Netherlands ksijssens@ooghazunlFAU - Sijssens, Karen M
    Abstract:

  34. SIRONI M, MARTINEZ FO, D'AMBROSIO D, GATTORNO M, POLENTARUTTI N, LOCATI M, GREGORIO A, IELLEM A, CASSATELLA MA, VAN DAMME J, SOZZANI S, MARTINI A, SINIGAGLIA F, VECCHI Aet MANTOVANI A: Differential regulation of chemokine production by Fc{gamma} receptor engagement in human monocytes: association of CCL1 with a distinct form of M2 monocyte activation (M2b, Type 2), J Leukoc Biol., Vol. ., 2006
    Organism:*Department of Immunology and Cell Biology, Mario Negri Institute for Pharmacological Research, Milan, Italy; Institute of General Pathology, Medical Faculty, University of Milan, Italy; BioXell, Milan, Italy; II Division of Pediatrics, University of Genoa, Italy; paragraph signDepartment of Pathology, University of Verona, Italy; Laboratory of Molecular Immunology, Rega Institute for Medical Research, Leuven, Belgium; and **Department of Biotechnology, Division of General Pathology and Immunology, University of Brescia, Italy
    Abstract:

  35. STABILE A, BERTONI B, ANSUINI V, LA T, I, SALLI Aet RIGANTE D: The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age, Eur Rev Med Pharmacol Sci., Vol. 10, 53-59., 2006
    Organism:Department of Pediatric Sciences, Catholic University Sacro Cuore, Rome, Italy astabile@rmunicattitFAU - Stabile, A
    Abstract:

  36. STARK LJ, DAVIS AM, JANICKE DM, MACKNER LM, HOMMEL KA, BEAN JA, LOVELL D, HEUBI JEet KALKWARF HJ: A randomized clinical trial of dietary calcium to improve bone accretion in children with juvenile rheumatoid arthritis, J Pediatr., Vol. 148, 501-507., 2006
    Organism:Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center/University of Cincinnati College of Medicine, OH 45229, USA LoriStark@chmccorgFAU - Stark, Lori J
    Abstract:

  37. STEERE AC, KLITZ W, DROUIN EE, FALK BA, KWOK WW, NEPOM GTet BAXTER-LOWE LA: Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide, J Exp Med., Vol. 203, 961-971., 2006
    Organism:Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA asteere@partnersorgFAU - Steere, Allen C
    Abstract:

  38. SZUMERA M, SIKORSKA-WISNIEWSKA G, SZWEDA Pet KORZON M: [Role of parvovirus B19 as a causative agent for arthritis in children -- preliminary studies], Med Wieku Rozwoj., Vol. 8, 425-432., 2004
    Organism:Klinika Pediatrii, Gastroenterologii i Onkologii, Dziecieca Akademia Medyczna, 80-803 Gdansk, PolandFAU - Szumera, Malgorzata
    Abstract:

  39. THAPA BR: Therapeutic potentials of bovine colostrums, Indian J Pediatr., Vol. 72, 849-852., 2005
    Organism:Division of Pediatric Gastroenterology, Postgraduate Institute of Medical Education and Research Chandigarh, India brthapa1@yahoocoinFAU - Thapa, B R
    Abstract:

  40. THORNTON J, ASHCROFT DM, MUGHAL Z, ELLIOTT RA, O'NEILL TWet SYMMONS D: Systematic review of effectiveness of bisphosphonates in treatment of low bone mineral density and fragility fractures in juvenile idiopathic arthritis, Arch Dis Child., Vol. ., 2006
    Organism:University of Manchester, United Kingdom
    Abstract:

  41. TWILT M, SCHULTEN AJ, NICOLAAS P, DULGER Aet SUIJLEKOM-SMIT LW: Facioskeletal changes in children with juvenile idiopathic arthritis, Ann Rheum Dis., Vol. 65, 823-825., 2006
    Organism:Erasmus MC Sophia Children's Hospital, Department of Paediatrics, Sp 1545, PO Box 2060, 3000 CB Rotterdam, The Netherlands mtwilt@erasmusmcnl
    Abstract:

  42. WARREN S: Sleep in medically compromised children, Med Health R I., Vol. 89, 100-101., 2006
    Organism:The Advisory Board Company, Washington, DC 20037, USA sharonwarren05@gmailcomFAU - Warren, Sharon
    Abstract: